December 6, 2017 4:31 pm

Law firm expands class action against N.B. marijuana producer, alleges physical harm

Growing cannabis plants intended for the medical marijuana market are shown at OrganiGram in Moncton, N.B., on April 14, 2016.

The Canadian Press

A Nova Scotia law firm leading a proposed class action lawsuit against a New Brunswick medical marijuana producer is expanding its claim.

Wagners Law Firm initially filed a class action in March against OrganiGram, alleging the company breached its contract with customers by using unauthorized pesticides in their product.

READ MORE: Lawsuit filed against N.B. marijuana producer

Story continues below

Wagners now says the products have caused “physical harm to clients” and has amended that claim.

“[We have] received several reports from clients of negative health effects that began after consuming the recalled product. Commonly reported effects are vomiting, dizziness and nausea,” the law firm said in a news release.

Wagners alleges roughly 2,000 people purchased cannabis products containing myclobutanil and bifenazate from the Moncton-based company last year.

The law firm says both chemicals are considered toxic and are not authorized for use on medical cannabis, and says users are worried about the health effects.

WATCH: Moncton marijuana producer OrganiGram expects big crowds for job fair

In January, Health Canada advised there was a voluntary recall by OrganiGram of dried marijuana and cannabis oil.

READ: NB marijuana producer Organigram hires law firm to battle class-action lawsuit

In response, OrganiGram issued a statement to Global News.

“At this time, OrganiGram cannot comment on ongoing litigation but as of this date the company can confirm that it has not been provided any medical evidence documenting any adverse health reaction,” it reads.

© 2017 Global News, a division of Corus Entertainment Inc.

Report an error


Want to discuss? Please read our Commenting Policy first.